PrairieView Partners’s Eli Lilly LLY Stock Holding History

PrairieView Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$667K	Hold	856	–	–	0.06%	81
2025 Q1	$707K	Buy	856 +30	+4%	+$25K	0.07%	74
2024 Q4	$637K	Hold	826	–	–	0.07%	78
2024 Q3	$731K	Buy	826 +10	+1%	+$8.99K	0.08%	72
2024 Q2	$738K	Hold	816	–	–	0.08%	75
2024 Q1	$635K	Buy	816 +12	+1%	+$8.54K	0.07%	69
2023 Q4	$469K	Hold	804	–	–	0.06%	81
2023 Q3	$431K	Hold	804	–	–	0.06%	77
2023 Q2	$377K	Buy	804 +4	+0.5%	+$1.68K	0.05%	85
2023 Q1	$274K	Hold	800	–	–	0.04%	94
2022 Q4	$292K	Buy	800 +200	+33%	+$70.9K	0.04%	89
2022 Q3	$194K	Hold	600	–	–	0.03%	102
2022 Q2	$195K	Buy	600 +100	+20%	+$30K	0.03%	103
2022 Q1	$143K	Hold	500	–	–	0.02%	125
2021 Q4	$138K	Hold	500	–	–	0.02%	120
2021 Q3	$116K	Buy	+500	New	+$123K	0.02%	127

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PrairieView Partners's LLY Position: Q2 2025 in Review

PrairieView Partners held its Eli Lilly (LLY) position steady in Q2 2025 at 856 shares worth $667K. The position accounts for 0.06% of the portfolio, ranked #81.

PrairieView Partners first reported a position in LLY in Q3 2021 and has held it in 16 quarters since. The position peaked at $738K in Q2 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

PrairieView Partners held 856 shares of Eli Lilly worth $667K as of Q2 2025.
PrairieView Partners left its Eli Lilly share count unchanged in Q2 2025.
Eli Lilly made up 0.06% of PrairieView Partners's portfolio in Q2 2025, its #81 holding.
PrairieView Partners first reported a position in Eli Lilly in Q3 2021 and has held it in 16 quarters since.
PrairieView Partners's Eli Lilly position peaked at $738K in Q2 2024.
3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.